The idea that antibiotics may cause breast cancer was first given a lot of attention upon publication of a 2004 study that reported a connection between the two. The study was roundly criticized by other researchers at the time for its lack of control for other patient characteristics known to contribute to breast cancer risk. Studies published since then have reported inconsistent results; most have found either a small positive association between breast cancer and antibiotic use or no significant association.
Some very large population studies have been undertaken to try to settle this question. However, the prescription and cancer databases that facilitate such large studies are typically not able to provide data concerning confounding factors for the subjects. It is possible that the use of antibiotics simply reflects health deficits such as chronic inflammation, chronic infection, or a weakened immune system that in themselves increase breast cancer risk. However, available evidence suggests that some antibiotics might promote breast cancer in some women.
Some antibiotics have been associated with increased breast cancer risk
The following antibiotics and antifungals have been found to be associated with increased breast cancer rates in at least one study:
- Cipro (ciprofloxacin)
- Flagyl (metronidazole)
- Garamycin (gentamicin)
- Grisovin (griseofulvin)
- TMP/SMX drugs such as Septra or Bactrim (trimethoprim/sulfamethoxazole or cotrimoxazole)
- Tetracyclines such as Sumycin, Terramycin, Tetracyn, and Panmycin.
Possible reasons for link between antibiotics and breast cancer
Several explanations have been proposed for the possible connection between antibiotic use and breast cancer. Antibiotics affect multiple organs, not just the bacteria they are intended to combat. Antibiotics reduce the diversity of intestinal microflora and may interfere with the ability of such microflora to metabolize plant phytochemicals into compounds that protect against cancer. Antibiotic use also affects the immune system and inflammation in ways that may increase breast cancer risk. In addition, antibiotics have been shown to disturb bone metabolism, with unknown effects on the potential to develop bone metastases.
There is also evidence that antibiotics may affect breast tissue directly. Breast tumor tissue and paired normal adjacent tissue from the same women using antibiotics have been found to contain different types and levels of bacteria. The total bacterial DNA load has also been found to be reduced in tumor versus paired normal tissue in antibiotic users.
A study of mice that spontaneously develop mammary tumors that overexpress HER-2/neu (HER2+) found that mice administered either Garamycin or a combination of Cipro and Flagyl developed more tumors than similar untreated mice. The mammary glands of the mice who were treated were found to have more numerous and more developed terminal ductal lobular units than control mice. This suggests that the breasts themselves may be altered by antibiotic exposure.
On the other hand, a 2018 study reported that Cipro induced the apoptosis (programmed cell death) of triple negative breast cancer cells in a dose- and time-dependent manner.
Antibiotics in food
Antibiotics are routinely administered to livestock (including poultry) and farmed fish to help reduce infections in the crowded conditions in which they are raised. Milk typically contains measurable quantities of antibiotics. Based on other evidence concerning these foods and the risk of breast cancer, beef, pork, lamb, and milk should be avoided, and organic rather than non-organic chicken (and other poultry) should be purchased, if possible. Wild salmon and other fatty fish are preferable to farm raised fish because they normally have higher omega-3 content, in addition to not having been raised using antibiotics and pesticides.
Based on the available evidence, we conclude that the association between overall antibiotic use and breast cancer is not strong and causality has not been shown. Women should continue to follow the prevailing medical advice to limit antibiotic use to when it is strictly medically necessary and to complete any course of antibiotics once it has been started. Serious infections can be deadly or cause permanent injury and should be treated appropriately.
Below are links to recent studies on this topic. For a more complete list of studies, please click on antibiotics.